National Cancer Centre Japan

Recent papers from National Cancer Centre Japan

1. Identification and prognostic value of non-hotspot POLE exonuclease domain mutations in endometrial cancerESMO Open · 2026
2. A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removedFuture Oncology · 2026
3. Association of pretreatment immune microenvironment profile with boron neutron capture therapy efficacy in cutaneous tumors: results from an ancillary multiplex immunofluorescence studyJournal of Radiation Research · 2026
4. Joint Effects of ALDH2 rs671 and Pathogenic Germline Variants in DNA Repair Genes on Risk of Aerodigestive and Gastrointestinal CancersCancer Epidemiology Biomarkers & Prevention · 2026
5. Multi-institutional classification of lesions in breast MRI: a comparison of one-stage and two-stage methodsJournal of medical imaging · 2026
6. Multi-ancestry genome- and transcriptome-wide association studies expand the susceptibility landscape for breast cancer overall and across subtypesCommunications Medicine · 2026
7. Nanoengineered STING agonists for cancer therapy: toward immunodynamic controlJournal of Hematology & Oncology · 2026
8. Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trialEndoscopy · 2026
9. Divergent genomic evolution in astrocytomas and oligodendrogliomasNature · 2026
10. Cancer in the Oldest‐Old in Super‐Aging Japan: Trends and Characteristics From National Registry DataInternational Journal of Cancer · 2026
11. Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 studyThe Lancet · 2025
12. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023The Lancet · 2025
13. Presence at the time of death and factors associated with dying alone: A nationwide registry studyDeath Studies · 2026
14. A plain language summary of the 7-year results from the CROWN study: lorlatinib compared with crizotinib in people with ALK-positive non-small cell lung cancerFuture Oncology · 2026
15. A study to learn how well HER3-DXd (patritumab deruxtecan) works and how safe it is in people with previously treated non-small-cell lung cancer that has a mutation in the EGFR gene: a plain language summary of the HERTHENA-Lung01 studyFuture Oncology · 2026
16. FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphomaEMBO Molecular Medicine · 2026
17. Dietary intake of vitamins B1, B2, B3, and B6, and the risk of gastric cancer: pooled analyses within the Stomach cancer Pooling (Stop) projectEuropean Journal of Nutrition · 2026
18. Efficacy and Safety of Alectinib in Pediatric and Adult Patients with ALK-Altered Advanced Solid Tumors: a phase II TACKLE Trial (NCCH1712/MK003)Clinical Cancer Research · 2026
19. Treatment Outcomes for Gastric Cancer With Positive Peritoneal Lavage Cytology or Localized Peritoneal MetastasisJAMA Surgery · 2026
20. Survival Results by the Prospectively Determined Clinical Staging for Locally Advanced Gastric Cancer: A Follow‐Up Study of JCOG1302AAnnals of Gastroenterological Surgery · 2026